Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
Harry Bleiberg(Institut Jules Bordet), Tarek Sahmoud(European Organisation for Research and Treatment of Cancer), Francesca Gay(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Laurent Bedenne(CHU Dijon Bourgogne), Pietro De Besi(University of Padua), B Paillot(Centre Henri Becquerel), Laurence Collette(GlaxoSmithKline (Belgium)), M. Namer(Centre Antoine Lacassagne), G.H. Blijham(SURFsara (Netherlands)), Thierry Conroy(Inserm), J H Jacob(Centre François Baclesse), A.J. Lacave(Hospital Universitario Central de Asturias)
Cited by 347
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k